Shell Asset Management Co. increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 223.0% in the first quarter, HoldingsChannel.com reports. The firm owned 3,585 shares of the biotechnology company’s stock after acquiring an additional 2,475 shares during the quarter. Shell Asset Management Co.’s holdings in Axon Enterprise were worth $1,122,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. raised its holdings in Axon Enterprise by 2.7% during the first quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after purchasing an additional 212,401 shares in the last quarter. Sands Capital Management LLC lifted its position in Axon Enterprise by 0.6% in the fourth quarter. Sands Capital Management LLC now owns 2,628,652 shares of the biotechnology company’s stock valued at $679,060,000 after acquiring an additional 16,347 shares during the last quarter. Norges Bank acquired a new position in Axon Enterprise in the fourth quarter valued at $195,406,000. Westfield Capital Management Co. LP boosted its stake in Axon Enterprise by 5.1% in the fourth quarter. Westfield Capital Management Co. LP now owns 731,721 shares of the biotechnology company’s stock valued at $189,025,000 after acquiring an additional 35,528 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in shares of Axon Enterprise by 2.8% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 580,757 shares of the biotechnology company’s stock worth $150,027,000 after purchasing an additional 15,840 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In other news, Director Julie A. Cullivan sold 478 shares of the company’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total transaction of $136,727.12. Following the transaction, the director now directly owns 5,546 shares of the company’s stock, valued at approximately $1,586,377.84. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, Director Julie A. Cullivan sold 478 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $286.04, for a total transaction of $136,727.12. Following the completion of the sale, the director now directly owns 5,546 shares in the company, valued at approximately $1,586,377.84. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, President Joshua Isner sold 44,000 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $309.96, for a total value of $13,638,240.00. Following the sale, the president now directly owns 275,843 shares in the company, valued at approximately $85,500,296.28. The disclosure for this sale can be found here. Insiders have sold a total of 89,447 shares of company stock worth $27,684,677 over the last three months. 6.10% of the stock is currently owned by corporate insiders.
Axon Enterprise Stock Performance
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.51 EPS. As a group, equities analysts predict that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several research firms have recently weighed in on AXON. Needham & Company LLC reissued a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a report on Tuesday, May 7th. Jefferies Financial Group started coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective for the company. Craig Hallum lifted their target price on shares of Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. JMP Securities reiterated a “market outperform” rating and issued a $375.00 price target on shares of Axon Enterprise in a research report on Tuesday, May 7th. Finally, JPMorgan Chase & Co. raised their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $342.54.
Read Our Latest Research Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Stories
- Five stocks we like better than Axon Enterprise
- 3 Warren Buffett Stocks to Buy Now
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- Which Wall Street Analysts are the Most Accurate?
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.